Microfluidic Antibiotic Susceptibility Testing via Resistance Fluctuations
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current antibiotic susceptibility testing methods are time-consuming and not suitable for point-of-care settings, as they require long incubation periods and often rely on complex techniques or labeling, which limits their utility in rapidly determining bacterial resistance.
Innovation Solution
A microfluidic system that detects live bacteria by monitoring resistance or conductivity fluctuations in a microchannel, allowing for rapid antibiotic susceptibility testing without the need for microscopy or labeling, using a reservoir connected to a microchannel where bacteria can swim in and out, and electrodes to trap or guide bacteria for efficient detection.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If standard antibiotic susceptibility tests (broth dilution or disk diffusion) are performed, then accurate determination of bacterial susceptibility is achieved, but the testing time is excessively long (16-24 hours)
Solution Approach 1:
The patent applies preliminary action by performing electrical resistance measurements on bacteria immediately after inoculation, before significant growth occurs. The system establishes a baseline resistance measurement and then monitors changes over a short period (hours rather than days), detecting susceptibility based on early metabolic changes or growth trends rather than waiting for full colony development. This allows rapid determination of susceptibility while maintaining accuracy through continuous monitoring of resistance changes.
2Loss of time
If rapid detection methods are developed, then testing time is reduced, but measurement precision and reliability may be compromised
Solution Approach 1:
The patent implements feedback by continuously monitoring electrical resistance changes over time and using this dynamic information to determine susceptibility. The system measures resistance at multiple time points, tracks the rate and pattern of change, and compares these trends against expected patterns for susceptible versus resistant bacteria. This feedback-based approach allows rapid determination (within hours) while maintaining precision by analyzing the trajectory of change rather than relying on endpoint measurements.
3Measurement precision
If complex techniques or labeling are used to improve detection sensitivity, then measurement precision is improved, but device complexity increases
Solution Approach 1:
The patent extracts and eliminates the need for complex labeling techniques, microscopy, or sophisticated detection systems by using a simple electrical resistance measurement approach. The method relies on measuring the bulk electrical resistance of the bacterial suspension, which changes naturally as bacteria grow or metabolize in the presence of antibiotics. This extraction of unnecessary complexity components (no labels, no microscopes, no complex optics) maintains detection sensitivity while dramatically simplifying the device to basic electrical measurement circuitry.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables rapid and sensitive detection of live bacteria, reducing the complexity and time required for sample testing, and can be used at the clinical point of care, providing a label-free method for determining antibiotic susceptibility.
Implementation Method 1
The resistance or conductivity of electric currents through the channel can be monitored as the bacteria swim into and out of the microfluidic channel. The movement of the live bacteria into and out of microfluidic channel can be detected as fluctuations in the measured resistance or conductivity.
Data Source
AI summary
A system and method for antibiotic susceptibility testing efficiently determines whether bacteria are alive or have been killed by antibiotic treatment. The antibiotic susceptibility testing device includes at least one reservoir into which a bacteria solution is introduced and a microfluidic channel connected to the reservoir, wherein the cross-sectional size of the microfluidic channel is selected to be comparable to the size of the bacterium to be tested. Furthermore, the electrical resistance or voltage signal across the microchannel is monitored as bacteria swim into and out of the channel. Alternatively, a small population of bacteria can be immobilized in the microchannel. The resistance or voltage signal fluctuates when the bacteria are alive and moving in and out of the channel or wiggling on the microchannel walls. If the bacteria are dead, they have limited motility and the signal fluctuations are significantly smaller. By monitoring the signal fluctuations, the antibiotic susceptibility testing device can determine whether or not bacteria are alive, thus enabling antibiotic susceptibility testing of bacteria.